Gene activation therapy: from the BLV model to HAM/TSP patients.
about
Roles of HTLV-1 basic Zip Factor (HBZ) in Viral Chronicity and Leukemic Transformation. Potential New Therapeutic Approaches to Prevent and Treat HTLV-1-Related DiseasesAnimal Models Utilized in HTLV-1 ResearchPreventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV.Blockade of bovine PD-1 increases T cell function and inhibits bovine leukemia virus expression in B cells in vitroConference highlights of the 16th International Conference on Human Retrovirology: HTLV and related retroviruses, 26-30 June 2013, Montreal, Canada.
P2860
Gene activation therapy: from the BLV model to HAM/TSP patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gene activation therapy: from the BLV model to HAM/TSP patients.
@en
Gene activation therapy: from the BLV model to HAM/TSP patients.
@nl
type
label
Gene activation therapy: from the BLV model to HAM/TSP patients.
@en
Gene activation therapy: from the BLV model to HAM/TSP patients.
@nl
prefLabel
Gene activation therapy: from the BLV model to HAM/TSP patients.
@en
Gene activation therapy: from the BLV model to HAM/TSP patients.
@nl
P2093
P50
P356
P1476
Gene activation therapy: from the BLV model to HAM/TSP patients.
@en
P2093
Agnes Lezin
Amel Bouzar
Arnaud Florins
Arsene Burny
Didier Smadja
Gildas Belrose
Julien Defoiche
Luc Willems
Nicolas Gillet
Olivier Verlaeten
P304
P356
10.2741/S20
P577
2009-06-01T00:00:00Z